SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-12-257412
Filing Date
2012-06-01
Accepted
2012-06-01 17:26:19
Documents
7
Period of Report
2012-07-10

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d335235dpre14a.htm PRE 14A 1019532
2 GRAPHIC g335235avi_logo.jpg GRAPHIC 1267
3 GRAPHIC g335235g22f01.jpg GRAPHIC 212591
4 GRAPHIC g335235g37k83.jpg GRAPHIC 5325
5 GRAPHIC g335235g39u20.jpg GRAPHIC 170770
6 GRAPHIC g335235g63n17.jpg GRAPHIC 5130
7 GRAPHIC g335235tx_pg56.jpg GRAPHIC 17463
  Complete submission text file 0001193125-12-257412.txt   1589947
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-14895 | Film No.: 12884268
SIC: 2834 Pharmaceutical Preparations